ABSTRACT The present study demonstrates a unique mechanism for tumor cell-induced immunosuppression. (SM# preceding PM+T may 
(SM#) are exposed to tumor cells prior to addition of PA4. If SM# and PM6 are simultaneously present with the tumor cIls, induction of suppression is completely precluded. These findings indicate that switching on of the suppressor mechanism by tumor cells has a critica requirement for the collaboration of two populations of macrophages, SMO and PMO, and their presence in a specific sequence (SM# preceding PM+T may represent one of the mechanisms by which tumor cells evade host immune surveillance. Recent studies indicate that the existence of various "check and balance" mechanisms may be essential for ensuring a proper immune response to antigenic stimulation (1, 2) . These mechanisns require the collaboration of various cellular and humoral compartments of the immune system. However, it may be the nature of some tumor cells to subvert this system by evoking reactions that offset these delicate check and balance mechanisms, thereby evading the host's immune surveillance, ensuring their survival. In this report, we present evidence to show that not only can tumor cells evade the host's immune defense system by directly suppressing the immune response but also they can activate a suppressor mechanism through the host's own immune surveillance network.
It has long been recognized that tumor cells or their products can be immunosuppressive (3) . We and others have shown that some tumor cells or an immunosuppressive factor(s) obtained from tumor bearers can suppress T cell-mediated tumor immunity (4, 5) . In previous studies we have shown that macrophages play an essential role in regulating the immune responses to tumor cells both in syngeneic (6, 7) and in allogeneic systems (8) . Due to the immunosuppressive nature of some tumor cells, it is difficult to study the relationship between immunogenicity and immunosuppression in the syngeneic system-i.e., immune response to tumor-associated antigens. Use of an allogeneic system allows us to dissociate the immunosuppressive and immunogenic properties of the tumor cells (8) , thereby making it possible to further examine the mechanisms for tumor cell suppression. In the present study we an appropriate responder-to-stimulator ratios (R/S). In some cultures, third-party 10,000 roentgen x-irradiated tumor cells were added at various responders-to-tumor cell ratios (R/T). Each flask usually contained a total of S ml of cultured cells. All cultures were established in 30-ml tissue culture flasks (Falcon) and incubated in an upright position at 370C in a humidified atmosphere containing 5% CO2. After 5 Cell-Mediated Cytotoxicity Assay. The 125IdUrd release assay was used to measure cell-mediated cytotoxicity. The details of the technique have been described elsewhere (14) . In brief, 0.05 ml of l25IdUrd-labeled target cells at 1 X 105/ml and 0.15 ml of effector cells at appropriate concentration were Abbreviations: MLC, mixed lymphocyte culture; R/S, responderto-stimulator ratio; R/T responder-to-tumor cell ratio; E/T, effectorto-target cell ratio; PC, peritoneal cells; MLTC, mixed lymphocyte tumor cell culture; PM+5, peritoneal macrophages; SMO, splenic macrophages. 4265
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. (8) . However, adding (PM+) at a latter time-e.g., 1 day after the initiation of MLTC-fails to reverse the tumor cell suppression; The standard MLC reaction was performed as described in 18- terrelationship of the different macrophage populations and their involvement in the generation of T cell-mediated cytotoxic response and in the tumor cell-induced immunosuppression, the following experiment was performed (the results are summarized in Table 4 ). Two responding groups were used, a normal unseparated splenic responder (groups 1-17) and a spleen population separated by a Sephadex G-10 column (groups 18-32), which was depleted of resident (splenic) macrophages. In these experiments allogeneic stimulators and syngeneic tumor cells, PC (PM+), or splenic adherent cells (SMO) were added at the onset (day 0) or at 1 or 2 days after initiation of MLC. Their effects on the generation of a cytotoxic response were then determined on day 5 of MLC. The findings obtained with unseparated spleen cells as responders (groups 1-17) can be summarized as follows: (i) Suppression could only be induced when PM4, not SM4, were present 1 day after addition of tumor cells to MLC, regardless of whether the stimulators were added on day 0 (groups 6 and 11) or day 1 (group 17); that is, the responders (spleen cells) have to be preexposed to tumor cells prior to addition of PM+. (ii) Addition of PM4 and tumor cells simultaneously not only gave no suppression (groups 5, 10, and 16), it precluded the induction of suppression by further addition of PMq on day 1 (group 8). It should be noted that addition of either PM) or tumor cells (Meth A at R/T of 200/1) alone to MLC gave no suppression. The failure of SM4 to induce suppression (group 7) also suggests that only exogenous (peritoneal) macrophages (with respect to splenic responders) can produce such effect.
To further elucidate these points, we have carried out experiments using spleen cells separated by a Sephadex G-10 column as responders; they were first depleted of resident (splenic) macrophages (16) , then reconstituted with PMO or SM4 to determine the effects of these macrophages on MLC with or without tumor cells (groups 18-32). This approach should allow us to directly examine the functional diversity between SM/ and PM4 in tumor cell-induced immunosuppression. In these experiments, the stimulators and third-party tumor cells were added on day 0. Some different and unexpected results were obtained after reconstituting with PMO or SM4 on day 0, day 1, or both. As expected, responders depleted of SM4 gave no cytotoxic response (group 18), and the response could be fully restored by reconstituting with PM4 or SMq6 (groups 20-23) . It was unexpected to find that addition of either ClA (~sS PM4 or SM4 at the same time or at 1 day after addition of tumor cells did not induce suppression (groups 24-27). Furthermore, if macrophages of the same anatomic site (PM4 in group 28, SM4 in group 29) were added at both days 0 and 1, or if PM4 were added prior to SM4 (group 30), no suppression was seen. These findings appeared to be contradictory to the above observation that suppression could be induced if responders were preexposed to tumor cells prior to addition of PM4. However, this puzzle was quickly resolved by the finding that suppression could be induced only if the components of the culture were added in the right sequence after addition of tumor cells: SM4 must precede PM4 (group 31), and addition of PMO and SMO simultaneously with the tumor cells prevented the induction of suppression by further addition of PM4 on day 1 (group 32). These results clearly indicate that the induction of suppression not only requires the presence of tumor cells prior to PM4, but it also strictly requires the collaboration between two populations of macrophages (PM4 and SM45) and their presence in the correct sequence (SM4 prior to PMO), indicating a critical requirement of preexposure of SM4 to tumor cells.
Simultaneous presence of PMO and SM4 with tumor cells precludes the induction of suppression. It should be noted that tests of the splenic adherent cells (SM4) are also consistent with their being macrophages: they are adherent to plastic dishes, radioresistant, and resistant to anti-Thy 1.2 antibody lysis (not shown).
DISCUSSION
Immunosuppressive macrophages have been described in several systems (18) (19) (20) , and there is also evidence for phenotypic and functional heterogeneity of macrophages (15, (21) (22) (23) . In the present study, it is clearly shown that tumor cells at a nonsuppressive dose can induce suppression of immune response through the host's macrophages (Tables 1-3 ). How-. ever, in order to achieve this purpose, the tumor cells have to evade several levels of the host's immune network.
All the experiments presented in this paper have been repeated at least [3] [4] [5] [6] [7] [8] [9] [10] Proc. Natl. Acad. Sci. USA 77 (1980) to induce suppression upon further addition of peritoneal macrophages indicates that preexposure of tumor cells to T cells (group 26, Table 4 ) or to a mixture of T cells and (peritoneal) macrophages (group 28, Table 4 ) is not sufficient for inducing suppression, because these Sephadex G-10 column-separated spleen cells contain sufficient amounts of T cells. The tumor cell-triggered macrophage-mediated suppression has the critical requirement for both the SMO and PM) (group 31, Table 4 ).
The critical requirement for tumor cells and the collaboration of two populations of macrophages to induce suppression denotes the possible existence of a unique mechanism for tumor cell suppression. In this pathway, there is also a requirement for a specific sequence of addition of tumor cells and macrophages-the resident (splenic) macrophages (SMO) have to be preexposed to tumor cells prior to the addition of exogenous (peritoneal) macrophages (PM+) ( Table 4 ). These findings are in complete agreement with our previous report, which involved using tumor cells as stimulators in the MLTC reactions (17) . Furthermore, the simultaneous presence of peritoneal macrophages and tumor cells prevents the induction of suppression (Table 4 , groups 8 and 32). These results indicate that despite the fact that PMO are needed to induce suppression, the SMO hold the key for suppression. It is possible that such mechanisms may also operate in normal immune response reactions as part of host's check and balance mechanisms. That is, after the immune response is initiated, then at a proper time the exogenous macrophages are recruited to trigger the resident macrophages to generate a negative signal to terminate the immune response at a proper level. The presence of tumor cells may complicate the situation by switching on this suppressor mechanism prematurely. To safeguard against this possibility, if the host can recruit exogenous macrophages at the time of tumor cell presence, such suppression can be prevented. Thus the tumor cells must evade this checking mechanism before they can escape the host's immune surveillance network.
A hypothetical model for suppression is proposed to illustrate this intriguing phenomenon (Fig. 1) . The model is similar to the suggestion by Monroy and Rosati (24) that the cell-cell communication system has evolved from membrane structures originally meant for cell recognition in the mating process (25); in our experiments, the SM4, which hold the key for inducing suppression, behave like (-) cells possessing the receptors for the (+) cells (PM4O). The receptors on SMO are masked or semilocked in an unstimulated state. After the immune response has been initiated and generated to a certain level, the receptors in SMO are unmasked or unlocked, then the exogenous PM) are recruited to "mate" with the SMO by inserting some essential factors that will trigger the SMO to switch on the suppressor mechanism and to terminate the immune response at a proper level. However, tumor cells have the ability to unlock the SM4's receptors at an earlier stage, allowing them to "mate" with PMO, thereby prematurely switching on the suppressor mechanism that results in an abortive T-cell response. On the other hand, if PM4 and SMO are exposed to each other prior to tumor cells, because PM4 have another cellsurface component that can keep the SMc's receptors firmly locked, thus preventing the unlocking process and precluding the induction of suppression. Alternatively, there may be two subsets of PM) that can either "mate" with SMO or keep the receptors of SM4 firmly locked.
Not only does there appear to be a remarkable resemblance between host-tumor and host-parasite relationships, but also the methods that the tumor cells use to evade the host's immune surveillance are strongly reminiscent of the tactics of parasites (26) . They can jam the immune response by direct suppression, or they can subvert the immune system by switching on the host's own suppressor mechanism.
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